Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata
Conditions:   Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis Interventions:   Drug: Fecal material transfer therapy;   Procedure: 4mm Punch Biopsy of Scalp;   Diagnostic Test: Blood draw;   Procedure: Skin Microbiome sampling;   Procedure: Hair Microbiome Sampling;   Drug: Pre-FMT Antibiotic Cocktail;   Drug: Bowel Prep Sponsor:   Columbia University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2020 Category: Research Source Type: clinical trials

Clinical Application of Stem Cell Educator Therapy in Alopecia Areata
Conditions:   Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis Intervention:   Combination Product: Stem Cell Educator therapy combined with minoxidil Sponsors:   Tianhe Stem Cell Biotechnologies Inc.;   Yale University;   Hackensack Meridian Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 8, 2019 Category: Research Source Type: clinical trials

ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)
Conditions:   Alopecia Areata;   Alopecia Universalis;   Alopecia Totalis Intervention:   Drug: ATI 502 0.46% Topical Solution Sponsor:   Aclaris Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2018 Category: Research Source Type: clinical trials

ATI-501 Oral Suspension Compared to Placebo in Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis
Condition:   Alopecia Intervention:   Drug: ATI-501 Sponsor:   Aclaris Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 20, 2018 Category: Research Source Type: clinical trials

Open Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia Areata
Conditions:   Alopecia Areata;   Alopecia Totalis;   Alopecia Universalis Intervention:   Drug: ATI-50002 Sponsor:   Aclaris Therapeutics, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2018 Category: Research Source Type: clinical trials